Dr. Steven C. Cramer | Assoc. Professor, Neurology, Department of Anatomy and Vascular Neurobiology Dr. Steven Cramer is an Associate Professor of Neurology and Anatomy & Neurobiology at the University of California, Irvine (UCI). He is board certified in Internal Medicine, Neurology, and Vascular Neurology, and directs the UCI Medical Center Stroke Center. Other contributions include Associate Clinical Director for the UCI Stem Cell Research Center and Director of the Neuroimaging Core of the General Clinical Research Center. His research interests focus on recovery of function after central nervous system (CNS) injury, particularly recovery of movement. Some of Dr. Cramer’s studies have examined the mechanisms underlying recovery after CNS injury, particularly in subjects with stroke or spinal cord injury. Dr. Cramer’s current work is focused on applying these insights to maximize gains from restorative interventions. Restorative therapies under study in Dr. Cramer’s lab include: cell therapy, small molecules to modulate specific neurochemical systems, neurotrophic factors, brain stimulation, motor imagery, and robotic therapy.
Dr. Hannelore Ehrenreich | Professor of Psychiatry and Neurology Dr. Hannelore Ehrenreich graduated in medicine and veterinary medicine specializing in clinical neurology and psychiatry at the universities of Hanover and Munich, Germany. From 1989-1992 she was a postdoctoral fellow at the National Institute of Allergy and Infectious Disease, National Institutes of Health, USA. Dr. Ehrenreich is now a Professor of Psychiatry and Neurology at the Max-Planck-Institute of Experimental Medicine and the University of Göettingen, Germany. For over 15 years she has been performing translational medicine, working on novel concepts for the treatment of neuropsychiatric disease, including alcoholism (treatment and regeneration after abstinence), brain disorders (ischaemia/oxygen deficiency, neurotrauma), and the regulation of vasoactive factors in the CNS. Since 1994 she has been investigating the neuroprotective and neuroregenerative effects of erythropoietin and brain disease. She has over 120 publications in peer-reviewed international journals.
Dr. Michael D Hill | Foothills Medical Center, University of Calgary, Canada. Dr. Michael Hill received undergraduate training in Biochemistry at McGill University, completed medical school and an internal medicine residency at the University of Ottawa and undertook further residency training in neurology at the University of Toronto. At the University of Calgary, Dr. Hill completed fellowship training in Stroke Neurology and received a Master’s degree in Clinical Epidemiology. Dr. Hill is currently primarily appointed as Associate Professor in the Department of Clinical Neurosciences with cross-appointments to Medicine and Community Health Sciences at the University of Calgary. Dr. Hill’s areas of research interests include clinical trials in stroke and the use of administrative data for stroke research and surveillance. He has participated in multiple clinical trials, leads the Calgary Stroke Program Clinical Trials Group and is leading four large clinical trials as the Principal Investigator (PI), co-PI or Steering Committee member.
|